...
....
Pharmaceutical
Biotechnology

> See specialized channels
Medical Devices & Diagnostics
> See specialized channels
Industrial
Biotechnology
> See specialized channels


  Join us

  Follow us on Twitter   Join our LinkedIn Group   Our Blog

Biotech News App
Provides access to the latest biotech press releases ...more

Android_Logo App Store RIM_Logo_small

Media Partnership:
Want to have your RSS feed integrated on our website? Contact us
RSS Feeds RSS Feeds
JoomlaWatch Stats 1.2.9 by Matej Koval
For Editors
Sign up for press releases
For Companies
Sign up for our newsletter
Back to PRESS RELEASES - 

Sartorius Stedim Biotech Introduces Advanced System for Agar and Membrane Transfer

| Print |
Monday, 30 September 2013 13:00 (UTC + 2)

sarto-stedim-bio logo

 Microsart® @media: Maximum Safety in Microbiological Quality Control

Goettingen, Germany | Aubagne, France, September 30, 2013 / B3C newswire / – Sartorius Stedim Biotech (SSB), a leading global supplier for the pharmaceutical and biotech industries, is introducing Microsart @media to complement Microsart @vance, a product line for microbiological quality control in these sectors.

Microsart @media are agar media dishes for Microbial Limits Testing according to the USP (Chapter <61>) and EP (Chapter 2.6.12). They are pre-filled with various agar media types, such as Tryptic Soy Agar or R2A Agar, sterile packaged and ready-to-use in combination with Microsart @filter units. Moreover, the Microsart @media features an innovative patented lid that allows touch-free transfer of the filter membrane onto the media without using any tweezers. In addition, easy access to the colonies after incubation is given due to the liftable lid. The intelligent design and ease of use eliminates almost all handling mistakes.

The combination of Microsart @media and Microsart @filters introduce a brand-new agar and membrane transfer concept. Thanks to their concerted development the matching Microsart @media active lid fits perfectly onto the Microsart @filter base. The few steps required between sampling and incubation save time and labor, while delivering more reliable results. The touch-free membrane transfer eliminates membrane manipulation and handling, thereby minimizing a major source of secondary contamination.

Current Image File :

Microsart media
For high resolution, please click on image.

Links for downloading:
www.sartorius.com/fileadmin/media/global/company/microsart_addmedia_application.jpg
www.sartorius.com/fileadmin/media/global/company/microsart_addmedia_product.jpg


A profile of Sartorius Stedim Biotech
Sartorius Stedim Biotech is a leading provider of cutting-edge equipment and services for the development, quality assurance and production processes of the biopharmaceutical industry. Its integrated solutions covering fermentation, cell cultivation, filtration, purification, fluid management and lab technologies are supporting the biopharmaceutical industry around the world to develop and produce drugs safely, timely and economically. Sartorius Stedim Biotech focuses on single-use technologies and value-added services to meet the rapidly changing technology requirements of the industry it serves. Strongly rooted in the scientific community and closely allied with customers and technology partners, the company is dedicated to its philosophy of “turning science into solutions.”

Headquartered in Aubagne, France, Sartorius Stedim Biotech is listed on the Eurolist of Euronext Paris. With its own manufacturing and R&D sites in Europe, North America and Asia and a global network of sales companies, Sartorius Stedim Biotech enjoys a worldwide presence. Its key manufacturing and R&D site is in Germany.
The company employs approx. 3,000 people, and in 2012 earned sales revenue of 544.0 million euros.

 

Contact:
Dominic Grone
Group Corporate Communications
Sartorius Administration GmbH
Phone:+49 (0)551 308 3324
email: This e-mail address is being protected from spambots. You need JavaScript enabled to view it This e-mail address is being protected from spambots. You need JavaScript enabled to view it This e-mail address is being protected from spambots. You need JavaScript enabled to view it
www.sartorius.com